FIGURE 2.

Comparison of the cumulative event-free survival rates among groups. Group A: asprin + clopidogel + atorvastatin + lansoprazole; Group B: asprin + clopidogel + atorvastatin; Group C: asprin + clopidogel + lansoprazole + rosuvastatin; Group D: asprin + clopidogel + rosuvastatin.